2023 Montana Legislature

Additional Bill Links       PDF version

Senate bill NO. 284

INTRODUCED BY C. Glimm

By Request of the ****

 

A BILL FOR AN ACT ENTITLED: "AN ACT REVISING LAWS RELATED TO REPORTING OF DRUGS TAKEN BY OR PRESCRIBED TO INDIVIDUALS WHOSE DEATHS ARE RULED TO BE SUICIDE; limited sharing of registry information involving individuals who completed suicide; requiring coroners to report available toxicology results for individuals who completed suicide; requiring a report on toxicology and controlled substances information in deaths ruled to be a suicide; extending rulemaking authority; and AMENDING SECTIONS 37-7-1506, 46-4-123, AND 53-21-1101, MCA.

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:

 

Section 1. Section 37-7-1506, MCA, is amended to read:

"37-7-1506. Providing prescription drug registry information. (1) Registry information is health care information as defined in 50-16-504 and is confidential. Except as provided in 37-7-1504, the board is authorized to provide data from the registry, upon request, only to the following:

(a)        a person authorized to prescribe or dispense prescription drugs if the person certifies that the information is needed to provide medical or pharmaceutical treatment to a patient who is the subject of the request and who is under the person's care or has been referred to the person for care;

(b)        a prescriber who requests information relating to the prescriber's own prescribing information if the prescriber certifies that the requested information is for a purpose in accordance with board rule;

(c)        an individual requesting the individual's registry information if the individual provides evidence satisfactory to the board that the individual requesting the information is the person about whom the data entry was made;

(d)        a designated representative of a government agency responsible for licensing, regulating, or disciplining licensed health care professionals who are authorized to prescribe, administer, or dispense drugs, in order to conduct investigations related to a health care professional who is the subject of an active investigation for drug misuse or diversion;

(e)        in accordance with the requirements of subsection (3), a designated representative of the department of public health and human services making an inquiry in accordance with 53-21-1101;

(e)(f)     a county coroner or a peace officer employed by a federal, state, tribal, or local law enforcement agency if the county coroner or peace officer has obtained an investigative subpoena;

(f)(g)     an authorized individual under the direction of the department of public health and human services for the purpose of reviewing and enforcing that department's responsibilities under the public health, medicare, or medicaid laws; or

(g)(h)    a prescription drug registry in another state if the data is subject to limitations and restrictions similar to those provided in 37-7-1502 through 37-7-1513.

(2)        The board shall maintain a record of each individual or entity that requests information from the registry and whether the request was granted pursuant to this section.

(3)        (a) The board may release information in summary, statistical, or aggregate form for educational, research, or public information purposes. The information may not identify a person or entity.

(b)        Without identifying the individual, the information released to the department of public health and human services for the purposes of subsection (1)(e) must include a list of all controlled substances dispensed to each person whose death was ruled to be a suicide.

(4)        Information collected by or obtained from the registry may not be used:

(a)        for commercial purposes; or

(b)        as evidence in any civil or administrative action, except in an investigation and disciplinary proceeding by the department or the agency responsible for licensing, regulating, or disciplining licensed health care professionals who are authorized to prescribe, administer, or dispense prescription drugs.

(5)        Information obtained from the registry in accordance with the requirements of this section may be used in the course of a criminal investigation and subsequent criminal proceedings.

(6)        (a) Registry information may be integrated into a health information system if the system:

(i)         limits access to the information to those individuals authorized under subsection (1) to receive registry information;

(ii)         meets the privacy and security requirements of the Health Insurance Portability and Accountability Act of 1996, 42 U.S.C. 1320d, et seq.; and

(iii)        meets other criteria established by the board by rule.

(b)        Information integrated into a health information system remains subject to the confidentiality requirements of 37-7-1505.

(7)        The board shall adopt rules to ensure that only authorized individuals have access to the registry and only to appropriate information from the registry. The rules must be consistent with:

(a)        the privacy provisions of the Health Insurance Portability and Accountability Act of 1996, 42 U.S.C. 1320d, et seq.;

(b)        administrative rules adopted in connection with that act;

(c)        Article II, section 10, of the Montana constitution; and

(d)        the privacy provisions of Title 50, chapter 16.

(8)        The procedures established by the board under this section may not impede patient access to prescription drugs for legitimate medical purposes."

 

Section 2. Section 46-4-123, MCA, is amended to read:

"46-4-123. Inquiry report. (1) The coroner shall make a full report of the facts discovered in all human deaths requiring an inquiry under the provisions of 46-4-122.

(2)        The inquiry report must be:

(a)        made using the Montana coroner death management system, if implemented and operational by the local agency;

(b)        initiated within 24 hours after the death investigation; and

(c)        completed as promptly as reasonable and commensurate with the availability of investigation information, excluding confidential criminal justice information and any other investigative material not necessary to determine cause or manner of death until the case is closed or charges are filed.

(3)        For a death ruled to be a suicide, the report must include the results of any toxicology testing done as a part of the inquiry. The coroner of a county that has not implemented the Montana coroner death management system shall report the information required under this subsection to the department of public health and human services in the manner prescribed by the department.

(3)(4)     The coroner and the medical examiner must each have access to the system. The coroner shall make a copy of the system inquiry report available to the county attorney."

 

Section 3. Section 53-21-1101, MCA, is amended to read:

"53-21-1101. Suicide prevention officer -- duties. (1) The department shall implement a suicide prevention program administered by a suicide prevention officer attached to the division responsible for administering adult mental health services. The program must be informed by the best available evidence.

(2)        The suicide prevention officer shall:

(a)        coordinate all suicide prevention activities being conducted for both children and adults by all divisions within the department and coordinate with any suicide prevention activities that are conducted by other state agencies, including the office of the superintendent of public instruction, the department of corrections, the department of military affairs, the university system, and other stakeholders;

(b)        develop a biennial suicide reduction plan in accordance with 53-21-1102 that addresses reducing suicides by Montanans of all ages, ethnic groups, and occupations;

(c)        request from the prescription drug registry provided for in 37-7-1502 a list of all controlled substances dispensed to each person whose death was ruled to be a suicide;

(d)        report to the legislature annually, in accordance with 5-11-210 and subsection (3) of this section, on the toxicology information submitted by county coroners and the prescription drug registry information regarding the medications prescribed to individuals whose manner of death was ruled to be a suicide; and

(c)(e)     direct a statewide suicide prevention program with activities based on the best available evidence that include but are not limited to:

(i)         conducting statewide communication campaigns aimed at normalizing the need for all Montanans to address their mental health and utilizing both paid and free media, including digital and social media, and including input from government agencies, school representatives from elementary schools through higher education, mental health advocacy groups, veteran groups, and other relevant nonprofit organizations;

(ii)         initiating, in partnership with Montana's tribes and tribal organizations, communication and training that is culturally appropriate and utilizes the modalities best suited for Indian country;

(iii)        seeking opportunities for research that will improve understanding of suicide in Montana and provide increased suicide-related services;

(iv)        training for medical professionals, military personnel, school personnel, social service providers, and the general public on recognizing the early warning signs of suicidality, depression, and other mental illnesses as well as actions, based on the best available evidence, to take during and after a crisis;

(v)        identifying and using available resources, which may include providing grants to entities, including but not limited to tribes, tribal and urban health organizations, local governments, schools, health care providers, professional associations, and other nonprofit and community organizations, for development or expansion of evidence-based suicide prevention programs in accordance with the requirements of 53-21-1111;

(vi)        building a multifaceted, lifespan approach to suicide prevention; and

(vii)       obtaining, analyzing, and reporting program evaluation data, quality health outcomes, and suicide morbidity and mortality data, subject to existing confidentiality protections for the data.

(3)          The suicide prevention officer may coordinate with appropriate department personnel in preparing the report required under subsection (2)(c). The report may contain only deidentified information."


Latest Version of SB 284 (SB0284.003)
Processed for the Web on April 18, 2023 (10:18AM)

New language in a bill appears underlined, deleted material appears stricken.

Sponsor names are handwritten on introduced bills, hence do not appear on the bill until it is reprinted.

See the status of this bill for the bill's primary sponsor.

  Status of this Bill | 2023 Legislature | Leg. Branch Home
All versions of this bill (PDFformat)
Authorized print version of this bill (PDFformat)
[
NEW SEARCH ]

Prepared by Montana Legislative Services
(406) 444-3064